Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × trastuzumab deruxtecan × Clear all

NCT07428044 2026-02-23

HERCULES

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06250777 2026-02-09

ELPIS

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT04644237 2025-11-21

DESTINY-LUNG02

Phase 2 Completed

152 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT03334617 2025-10-27

HUDSON

Phase 2 Active not recruiting

528 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT03505710 2025-05-30

DESTINY-Lung01

Phase 2 Terminated

181 enrolled 17 charts 1 FDA

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis